THURSDAY, May 26 (HealthDay News) — For men with advanced hormone-resistant prostate cancer who have also failed chemotherapy, the new drug Zytiga (abiraterone acetate) along with the steroid prednisone appears to boost survival, researchers report. Based on data from the ongoing clinical trial, Zytiga was approved by the U.S. Food and Drug Administration in April. [...]
Trend News
No comments:
Post a Comment